Your browser doesn't support javascript.
loading
Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells.
Zhao, Chengguang; Yang, Lehe; Zhou, Feng; Yu, Yun; Du, Xiaojing; Xiang, Youqun; Li, Chenglong; Huang, Xiaoying; Xie, Congying; Liu, Zhiguo; Lin, Jiayuh; Wang, Liangxing; Liang, Guang; Cui, Ri.
Afiliação
  • Zhao C; Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
  • Yang L; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Zhou F; Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedical, Wenzhou, 325035, Zhejiang, China.
  • Yu Y; Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
  • Du X; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Xiang Y; Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
  • Li C; Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
  • Huang X; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Xie C; Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
  • Liu Z; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Lin J; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Wang L; College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA.
  • Liang G; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
  • Cui R; The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
Oncogene ; 39(20): 3997-4013, 2020 05.
Article em En | MEDLINE | ID: mdl-32242147
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteínas Proto-Oncogênicas p21(ras) / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Proteínas Proto-Oncogênicas p21(ras) / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 Limite: Animals / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido